M. Huntürk ATİLLA, Leyla MEMİŞ, Ahmet KÖYBAŞIOĞLU, Erdoğan İNAL, S. Sabri USLU, M. Birol UĞUR, Fikret İLERİ

Steroid induced rhinocerebral mucormycosis: Report of a case

Yayın Aralığı: Yılda 4 Sayı
Yayıncı: Gazi Üniversitesi Tıp Fakültesi

Rhinocerebral mucormycosis is a potentially fatal fungal disease which may involve the nose, paranasal sinuses, orbit and central nervous system. Mucormycosis is most commonly seen in association with immunosuppression, diabetic acidosis, deferoxamine steroid and cytotoxic therapy, severe burns, AIDS, renal disease, malignancy or haematalogical disorders. Current treatment consists of correction of the underlying disorder, aggressive debridment of the wound, in combination with intravenous amphotericin B.

PDF

___

1. Peterson K L, Wang M, Canalis R£ Abemayor E. Rhinocerebral mucormycosis: evolution of the discese and treatment options. Laryngoscope 1997; 107: 555-862. 2. Butugan O, Sanchez TG, €ìonzaIez F. Venoza AR. Miniti
A. Rhiiiocerebral mucormycosis. predisposing t.actors. diagnosis. therapy, compli cations lind survival. Rev Laryngol Oto1 Rhinol 1996; 117: 53-55.
3. Bhattacharyya AK. Deshpande AR, Nayak SR. Kirtane M V, lngle MV, Vora 1M. Rhinocerebral mucormycosis: an unusual case presentation. J Laryngol (itol 1992; 106: 48- 49.
4. Dlitzer A, Lnwson W. Meyer.e DR. Bil ler HF. Patient .survival tactors in paranasal sirius mucomi ycos is. Laryngoscope 1980; 90: 635-64d.
5. Weir N. Wood-Golging G. lnfective rhinitis and sinusitis. In. kerr ACì (ed): Scott -Brown's Otolaryngology. 6tli ed. Oxiord: Butterworth - Heinemann. 1997; Vol 4: 40-41.
6 Bahadur S, Ghosh P, Chopra P, Rai G. Rhinocerebral phycomycosis. J Laryngol Otol 1997; 97: 267-270.
7. Pillsbury HC, Fischer ND. Rhinocerebritl mucormycosis. Arch Otolaryngol 1977; 103: 600-604.
8. Kohn R, Hepler R. Management of l imited rhino-orbital mucormycosis without exenteraiion. Opthalmol ogy 1985: 92: 1440-1444.